explore -WSS

explore

author：focus 2025-09-30 23:20:36 - browse：7878

WASHINGTON — For those already felled by fumes from the Brazilian Blowout, it might be small consolation, but lawmakers are pushing ahead with a campaign for better oversight of the beauty business.

Despite its booming growth, the cosmetics industry in the US has been virtually unregulated. The Food, Drug, and Cosmetic Act, adopted in 1938, essentially allowed personal care product companies to self-police.

But rising public concern over bad reactions to makeup, hair dyes, and fragrances, as well as evidence of long-term health risks from some of their chemical contents, has led lawmakers to try to toughen the regulatory framework for the $60 billion enhancement industry.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Apple is now the first public company to be valued at $3 trillion
Next article： UnitedHealth financials solid despite Change Healthcare cyberattack

WSS

Mega Millions pot grows to $1.25 billion after no winner

Orangutan used medicinal plant to treat wound, first time ever seen

What the airline industry can learn from medicine

What to expect as Trump is arraigned on his Jan 6. indictment

Bird flu outbreak in cows is latest avian flu curveball

Amazon expands telehealth clinic nationwide

knowledge

explore

explore

The cancer drug shortage isn’t new — and neither are the solutions

The high personal cost of affirmative action for Black doctors

Trump demands the U.S. pay no more for drugs than other countries … again

Sage hopes for a blockbuster in antidepressant now before FDA

Moonlake's readout produced a cash windfall. Risks remain

Medical bills so high, Medicare adding extra digits to claim forms

The cancer drug shortage isn’t new — and neither are the solutions

New safety details link Apellis eye drug to rare cases of blindness

Malaria cases in Florida and Texas: Here’s what you need to know

EQRx, failed developer of low

hotspot

Physician groups backed by private equity giant lobby on mergers

‘Oppenheimer’ and the risks of AI in health care

H5N1 bird flu virus started spreading in cows in Texas in December

Adults seen as increasingly susceptible to measles

Diversity in clinical trials starts with building trust, experts say

NIH launches clinical trials and new research office for long Covid

hotspot

hotspot

hotspot

focus